Zheng Y, Shi J
Discov Oncol. 2025; 16(1):249.
PMID: 40014231
PMC: 11868007.
DOI: 10.1007/s12672-025-01867-y.
Bilgin M, Bilgin S, Akkurt B, Heindel W, Mannil M, Musigmann M
Cancers (Basel). 2025; 17(2).
PMID: 39858104
PMC: 11763433.
DOI: 10.3390/cancers17020322.
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T
Hereditas. 2024; 161(1):54.
PMID: 39726023
PMC: 11670371.
DOI: 10.1186/s41065-024-00349-5.
Jia Y, Liu M, Liu H, Liang W, Zhu Q, Wang C
Cancer Biol Ther. 2024; 25(1):2425134.
PMID: 39555702
PMC: 11581156.
DOI: 10.1080/15384047.2024.2425134.
Yi L, Kong W, Jiu Z, Huang Z, Na P, Chen W
Transl Cancer Res. 2024; 13(10):5563-5573.
PMID: 39525013
PMC: 11543039.
DOI: 10.21037/tcr-24-1662.
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome.
Lin L, Yu H, Xie X, Lei Q, Chen X, Su X
Am J Cancer Res. 2024; 14(6):2731-2754.
PMID: 39005680
PMC: 11236777.
DOI: 10.62347/GIGO3446.
STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC.
Li Y, Jiang F, Zhu S, Jia H, Li C
Front Mol Biosci. 2024; 11:1419072.
PMID: 38948079
PMC: 11211654.
DOI: 10.3389/fmolb.2024.1419072.
LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis.
Zeng Y, Yang Z, Yang Y, Wang P
Cell Div. 2024; 19(1):17.
PMID: 38730506
PMC: 11088135.
DOI: 10.1186/s13008-024-00122-0.
A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z, Jiang Y, Yang Y, Kang X, Yan J, Liu B
Sci Rep. 2024; 14(1):9427.
PMID: 38658591
PMC: 11043340.
DOI: 10.1038/s41598-024-58434-8.
Dosimetric comparison of advanced radiation techniques for scalp-sparing in low-grade gliomas.
Yu H, He S, He Y, Dai G, Fu Y, Zeng X
Strahlenther Onkol. 2024; 200(9):785-796.
PMID: 38649484
DOI: 10.1007/s00066-024-02229-3.
Current Photodynamic Therapy for Glioma Treatment: An Update.
Aebisher D, Przygorzewska A, Mysliwiec A, Dynarowicz K, Krupka-Olek M, Bozek A
Biomedicines. 2024; 12(2).
PMID: 38397977
PMC: 10886821.
DOI: 10.3390/biomedicines12020375.
A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response.
Tang X, Wang K, Yang J, Wang Y, Yan Z
Am J Cancer Res. 2024; 14(1):324-343.
PMID: 38323285
PMC: 10839322.
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y, Wu X, Zhu J, Lu R, Ouyang Y
BMC Cancer. 2023; 23(1):1120.
PMID: 37978473
PMC: 10655456.
DOI: 10.1186/s12885-023-11637-0.
miR-21-5p inhibits the growth of brain glioma cells through regulating the glycolysis mediated by PFKFB2.
Zhang L, Liu J
Funct Integr Genomics. 2023; 23(4):322.
PMID: 37864733
PMC: 10590297.
DOI: 10.1007/s10142-023-01246-2.
Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas.
Guo Y, Bao J, Lin D, Hong K, Cen K, Sun J
Heliyon. 2023; 9(9):e20178.
PMID: 37809899
PMC: 10559968.
DOI: 10.1016/j.heliyon.2023.e20178.
Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma.
Zhu W, Chen Z, Fu M, Li Q, Chen X, Li X
Apoptosis. 2023; 29(1-2):169-190.
PMID: 37713112
PMC: 10830610.
DOI: 10.1007/s10495-023-01880-y.
Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations.
Damodharan S, Puccetti D
Brain Sci. 2023; 13(7).
PMID: 37509034
PMC: 10377074.
DOI: 10.3390/brainsci13071106.
Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma.
Sun F, Lv H, Feng B, Sun J, Zhang L, Dong B
Aging (Albany NY). 2023; 15(13):6264-6291.
PMID: 37405952
PMC: 10373982.
DOI: 10.18632/aging.204850.
ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?.
Haemmerli J, Sveikata L, Nouri A, May A, Egervari K, Freyschlag C
BMJ Health Care Inform. 2023; 30(1).
PMID: 37399360
PMC: 10314415.
DOI: 10.1136/bmjhci-2023-100775.
Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma.
Gu J, Pang L, Yan D, Wang C, Song Y, Jin Z
Aging (Albany NY). 2023; 15(8):2970-2998.
PMID: 37053008
PMC: 10188348.
DOI: 10.18632/aging.204650.